German General Merchandise and Department Stores Stock News

XTRA:WAF
XTRA:WAFSemiconductor

Siltronic (XTRA:WAF) Valuation Check After Private Placement And Rapid Share Price Rally

Siltronic (XTRA:WAF) has drawn fresh attention after announcing a private placement of 2,100,000 shares at €89.35 each, raising €187,635,000 and reaffirming Wacker Chemie AG as the largest shareholder at about 24%. See our latest analysis for Siltronic. The private placement headlines coincide with strong momentum in the stock, with a 30 day share price return of 39.6% and a year to date share price return of 105.29%. The 1 year total shareholder return stands at 189.23%, signalling that...
XTRA:EUZ
XTRA:EUZMedical Equipment

Assessing Eckert & Ziegler (XTRA:EUZ) Valuation After New Thor Medical Lead-212 Collaboration

Eckert & Ziegler (XTRA:EUZ) is back in focus after signing a collaboration and supply agreement with Thor Medical ASA, centered on lead-212 based radiopharmaceutical therapies and future production scale up. See our latest analysis for Eckert & Ziegler. The collaboration news arrives after a strong near-term run, with a 9.99% 7-day share price return and a 10.50% 30-day share price return. Over a longer horizon, the 1-year total shareholder return is down 19.19%, while the 3-year total...
XTRA:MBG
XTRA:MBGAuto

Assessing Mercedes-Benz Group (XTRA:MBG) Valuation After Mixed Recent Share Price Performance

Mercedes-Benz Group stock: performance snapshot after recent moves Recent trading in Mercedes-Benz Group (XTRA:MBG) has drawn attention after a mixed stretch, with the stock up about 7% over the past month but down roughly 12% over the past 3 months. See our latest analysis for Mercedes-Benz Group. At a share price of €52.19, Mercedes-Benz Group’s recent 7.05% 1 month share price return contrasts with a weaker 90 day share price return. The 1 year total shareholder return of 6.19% points to...
XTRA:ERAG
XTRA:ERAGCapital Markets

Ernst Russ (XTRA:ERAG) Q1 2026 Net Margin Strength Tests Bearish Earnings Narratives

Q1 2026 earnings snapshot for Ernst Russ (XTRA:ERAG) Ernst Russ (XTRA:ERAG) has opened 2026 with Q1 revenue of €41.0 million and net income of €11.0 million, setting a fresh reference point for investors watching the stock at around €9.10. The company has seen quarterly revenue move from €74.2 million in Q1 2025 to €41.0 million in Q1 2026, while trailing twelve month net income sits at €59.8 million against €42.5 million two years ago. This gives helpful context for how the latest quarter...
XTRA:NVM
XTRA:NVMAuto Components

Novem Group XTRA NVM Q4 Loss Tests Bullish Earnings Growth Narrative

Novem Group (XTRA:NVM) closed FY 2026 with fourth quarter revenue of €144.4 million and a net loss of €6.1 million, setting a mixed tone for the latest earnings snapshot. Over recent periods the company has seen quarterly revenue move from €137.964 million in Q4 2025 to €128.9 million in Q1 2026, €125.576 million in Q2 2026, €117.9 million in Q3 2026 and then €144.4 million in Q4 2026. EPS shifted from €0.050251 in Q4 2025 to €0.36 in Q1 2026, €0.063987 in Q2 2026 and a loss of €0.02 in Q3...
XTRA:DBK
XTRA:DBKCapital Markets

Assessing Deutsche Bank (XTRA:DBK) Valuation As Shares Trade Below A Widely Followed Fair Value Estimate

Deutsche Bank (XTRA:DBK) stock has been drawing attention after recent trading showed a mixed picture, with the price around €27.86 and returns varying between the past month, past 3 months, and year to date. See our latest analysis for Deutsche Bank. Short term, Deutsche Bank’s 1 day and 7 day share price returns both declined, while its 30 day share price return rose 3.97%. Longer term, total shareholder returns over 1, 3 and 5 years have been strong, suggesting momentum has cooled recently...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Bayer ASCO 2026 Oncology Data Puts NUBEQA And Valuation In Focus

Bayer plans to present 16 oncology abstracts at the 2026 ASCO Annual Meeting. Primary results from multiple cancer trials, including several Phase II studies, are set to be shared. The company will reveal head to head data from the Phase II ARACOG (AFT-47) trial of NUBEQA versus enzalutamide in advanced prostate cancer. Additional safety, efficacy, and subgroup analyses will cover a range of Bayer cancer therapies. Bayer (XTRA:BAYN), trading at around €36.53, has had mixed share...
XTRA:SAP
XTRA:SAPSoftware

A Look At SAP (XTRA:SAP) Valuation After Sapphire 2026 Autonomous Enterprise And Business AI Platform Updates

SAP (XTRA:SAP) is back in focus after Sapphire 2026, where the company outlined its Autonomous Enterprise vision and launched its Business AI Platform, supported by partner endorsements and fresh recognition for SAP Signavio. See our latest analysis for SAP. The recent Autonomous Enterprise announcements and partner wins around SAP’s Business AI Platform have coincided with a 1-month share price return of 6.24%. However, the stock is still down 23.26% year to date and the 1-year total...
XTRA:EVD
XTRA:EVDEntertainment

CTS Eventim (XTRA:EVD) EPS Beat Renews Debate On Premium Valuation Narratives

CTS Eventim KGaA (XTRA:EVD) opened Q1 2026 with revenue of €613.5 million and basic EPS of €0.66, giving investors a fresh look at how its ticketing and live events engine is translating into earnings. The company reported revenue of €498.6 million in Q1 2025 and €613.5 million in Q1 2026, while basic EPS increased from €0.48 to €0.66 over the same period. This frames a quarter where profitability signals appear alongside easing net margins over the last year. See our full analysis for CTS...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Technologies (XTRA:IFX) Valuation Checked After Strong Short Term Share Price Rally

Infineon Technologies stock: recent moves catch investors’ attention Infineon Technologies (XTRA:IFX) has drawn fresh interest after a strong recent run in its share price, with the stock up 4.4% over the past day and 17.8% over the past week. That momentum extends further, with gains of 51.7% over the past month and 74.8% over the past 3 months. This has prompted many investors to reassess what is currently priced into the €103.3b semiconductor company. See our latest analysis for Infineon...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Valuation Check As New AiM Robotics MRI Collaboration Gains Attention

Interest in Siemens Healthineers (XTRA:SHL) has picked up after AiM Medical Robotics announced a collaboration that links its MRI-compatible neurosurgery robot with Siemens Healthineers’ MAGNETOM MRI scanners for real-time, image-guided procedures. See our latest analysis for Siemens Healthineers. Despite the robotics collaboration and recent investor outreach, including a UBS roadshow and portfolio review in India, Siemens Healthineers’ share price has been weak, with a year to date share...
XTRA:BMW
XTRA:BMWAuto

Is BMW (XTRA:BMW) Offering Value After Recent Share Price Weakness And DCF Upside Estimates

Investors may be considering whether Bayerische Motoren Werke stock offers good value at today's price, or if the market is already fully reflecting its current story. The share price closed at €75.94, with a 7 day gain of 2.1%, but is down 4.3% over the past month and 21.2% year to date. The 1 year return sits at 2.3% and the 5 year return at 11.9%. These moves sit against a backdrop of ongoing attention on auto manufacturers, including debates about the balance between traditional...
DB:0QM
DB:0QMHospitality

Discovering Compa And 2 Other Promising European Penny Stocks

The European market has recently shown a positive trend, with the pan-European STOXX Europe 600 Index climbing by 3.00%, driven by hopes of easing tensions in the Middle East. Amidst this backdrop, investors are increasingly exploring diverse opportunities within the market, including penny stocks. Though often seen as an outdated term, penny stocks still represent a viable investment avenue for those seeking smaller or newer companies with strong financial foundations and growth potential.
XTRA:DHER
XTRA:DHERHospitality

Uber’s Delivery Hero Offer Reshapes Deal Scenarios And Shareholder Outcomes

Uber has made an indicative cash offer to acquire Delivery Hero, which the company rejected. Reports suggest Uber is preparing a higher bid and has built a 19.5% stake in Delivery Hero. Delivery Hero's board is reviewing options that include a full sale or divestitures of core regions. Regulatory and antitrust scrutiny are emerging as key considerations for any potential transaction. Delivery Hero (XTRA:DHER) sits at the center of a fast evolving M&A story, with Uber moving from suitor to...
XTRA:SAP
XTRA:SAPSoftware

Is There Now An Opportunity In SAP (XTRA:SAP) After A Steep Share Price Decline?

If you are wondering whether SAP at €151.80 offers value or risk at this point in the cycle, this article breaks down what the current price might be implying about the stock. The share price is broadly flat in the near term, with SAP up 0.6% over the past week and 2.0% over the past month. However, the stock is still down 24.8% year to date and down 41.2% over the past year, which may change how you think about its risk and return trade off. These moves sit against a backdrop of ongoing...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Should Kerendia Priority Review in Type 1 Kidney Disease Require Action From Bayer (XTRA:BAYN) Investors?

Earlier this month, Bayer announced that the U.S. FDA accepted a supplemental New Drug Application and granted Priority Review for Kerendia (finerenone) in adults with type 1 diabetes and chronic kidney disease, supported by Phase III FINE-ONE data showing significant reduction in urine albumin-to-creatinine ratio over six months alongside standard care. This move could broaden Kerendia’s use beyond its existing approvals in chronic kidney disease linked to type 2 diabetes and heart failure...
XTRA:VRV
XTRA:VRVMedia

Verve Group Q1 Loss Revives Bearish Narrative On Fragile Profitability

Verve Group (XTRA:VRV) opened 2026 with Q1 revenue of €146.0 million and a basic EPS loss of €0.01, as net income excluding extra items came in at a loss of €2.9 million. Over recent quarters, revenue has moved between €111.1 million and €208.2 million while basic EPS has ranged from a loss of €0.02 to a profit of €0.08. This highlights how quickly earnings can swing as margins shift. With revenue now at the higher end of its recent range but EPS back in loss making territory, the focus for...
XTRA:AG1
XTRA:AG1Specialty Retail

AUTO1 Group (XTRA:AG1): Do Profits, Cash Burn And Goldman’s Stake Align Into A Coherent Story?

AUTO1 Group SE recently reported profit growth but also disclosed a very large €487,000,000 cash burn over the last year, prompting analyst concerns about the lack of free cash flow and the quality of its earnings. At the same time, Goldman Sachs revealed it now controls about 9.20% of AUTO1 Group’s voting rights through shares and instruments, underscoring growing institutional attention just as questions emerge about how resilient those reported profits really are. We’ll now examine how...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Valuation Check After A Year Of Weak Share Performance

Fresenius Medical Care: recent share performance in focus Fresenius Medical Care (XTRA:FME) has come back onto investor radars after a period of weaker share performance, with the stock down 7.1% year to date and 25.6% over the past year. See our latest analysis for Fresenius Medical Care. The recent drift in momentum, with a 30 day share price return of 3.94% and a 1 year total shareholder return decline of 25.61%, suggests sentiment has cooled after earlier gains over three years. If the...
XTRA:DTG
XTRA:DTGMachinery

A Look At Daimler Truck Holding (XTRA:DTG) Valuation After Mixed Short And Long Term Share Returns

Daimler Truck Holding stock reacts to recent performance data Daimler Truck Holding (XTRA:DTG) has come into focus after fresh performance data highlighted a mixed return profile, with the stock up over the past year but down over the past month and past 3 months. See our latest analysis for Daimler Truck Holding. At a share price of €41.68, Daimler Truck Holding shows a 7 day share price return of 6.57% but is down 5.27% over 30 days, while the 1 year total shareholder return of 15.45% and 3...
XTRA:VOW3
XTRA:VOW3Auto

Volkswagen (XTRA:VOW3) Valuation Check As Recent Trading Sends Mixed Share Price Signals

Volkswagen (XTRA:VOW3) stock continues to draw attention after recent trading, with the shares last closing at €90.50. Investors are weighing this price against the company’s earnings profile and multi-brand global footprint. See our latest analysis for Volkswagen. Recent trading has been mixed, with a 7 day share price return of 3.29% but a year to date share price return down 14.98%, while the 1 year total shareholder return has declined 5.18%. This suggests that momentum has softened...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Offering Value After A Mixed Year Of Share Price Moves

If you are wondering whether Mercedes-Benz Group is attractively priced or not, the stock offers plenty of data points to test what you are really paying for. The share price recently closed at €50.92, with returns of 2.8% over the past 7 days, 2.3% over the past 30 days, a decline of 17.8% year to date, and a 5.6% gain over the past year. Together, these figures present a mixed picture of sentiment. Recent coverage around Mercedes-Benz Group has focused on its position in the Auto industry...